Company Financials

Soleno Therapeutics, Inc. Financials

United States dollar

business Soleno Therapeutics, Inc. Company Profile

Main Stock Listing

NASDAQ: SLNO

Market Capitalization $4.37 Billion as of July 1, 2025

Market Cap History

Valuations Metrics as of Jul. 4, 2025

Trailing PE
Forward PE -38.17
Price to Sales TTM $
Price to Book MRQ $18.10
Enterprise to Revenue
Enterprise to EBITDA -19.71

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-03-31
Profit Margin 0.00%
Operating Margin 0.00%
Return on Assets TTM -52.40%
Return on Equity TTM -105.54%

Income Statement

Revenue TTM $0
Revenue per Share TTM $
Quarterly Revenue Growth %
Gross Profit TTM $0
EBITDA $-202,130,000
Net Income to Common TTM $-198,224,992
Diluted EPS TTM $-4.74
Quarterly Earnings Growth YoY %

Balance Sheet

Total Cash MRQ $289,950,016
Total Cash per Share MRQ $5.75
Total Debt MRQ $
Total Debt to Equity MRQ 22.73
Current Ratio MRQ 19.64
Book Value per Share MRQ $4.79

Cash Flow

Operating Cash Flow TTM $-89,320,000
Levered Free Cash Flow TTM $-33,976,876

SLNO Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding 45,703,811
Float Shares 38,274,191
Avg 10 Volume 1,443,610
Avg 30 Volume None
Shares Short 4,063,932
Short Ratio 6.19
Short % of Shares 9.28%
% Held by Insiders 1.89%
% Held by Institutions 112.43%

Stock Price Summary

Beta -2.67
Fifty Two Week Low $40.19
Fifty Two Week High $87.16
Fifty Two Week Change 52.79%
Day 50 MA $77.44
Day 200 MA $58.45

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date 2017-10-06
Ex Dividend Date
Last Split Factor
Last Split Date 2022-08-26